Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer
Bringing more than 20 years of experience as a senior level executive in the global pharmaceutical and biotech industry, Francois Martelet will join Scandion Oncology on January 2, 2023.Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, announces that the company’s Board of Directors has appointed Francois Martelet as new Chief Executive Officer (CEO). Francois will take up his new position on January 2, 2023. Trained as a Medical Doctor with a Master’s degree in Business, Francois